Lutonix for dysfunctional arteriovenous fistulae shows improved primary patency vs. plain balloon angioplasty at...

Interim twelve-month data from the Lutonix AV Clinical Trial indicate that treatment of dysfunctional arteriovenous (AV) fistulae with Bard’s Lutonix drug-coated balloon (DCB) produces...

Alucent Medical receives FDA approval to begin Natural Vascular Scaffolding clinical trials

Alucent Medical has announced that it has received US Food and Drug Administration (FDA) approval to begin Phase 1 human clinical studies of Natural Vascular...

Endologix provides update on the Nellix sealing system US regulatory status

Endologix has met with the US Food and Drug Administration (FDA) regarding its Nellix endovascular aneurysm sealing system (EVAS System). Based upon that meeting and...

First patient enrolled and treated in the Altura stent graft ALTITUDE registry

Lombard Medical has now enrolled and treated the first patient in its global registry to evaluate its Altura endograft system. The ALTITUDE registry (Altura impact on the treatment of abdominal...

R Clement Darling III

Vincent Riambau

Dittmar Bӧckler